Pharmaceutical, biopharmaceutical and research organizations increasingly require reliable molecular data to support product development, contamination investigations, quality control and regulatory documentation. However, establishing every specialist capability in-house may require substantial investment in infrastructure, skilled personnel, validated workflows and bioinformatics expertise.
geneOmbio Technologies provides contract research services for organizations that need dependable genomic and molecular testing support. Its service portfolio includes microbial identification, cell bank characterization, DNA barcoding and other customized molecular research workflows for pharmaceutical companies, biotechnology organizations, research institutes, academic teams and related industries. The laboratory’s quality systems, sequencing capabilities and research experience are designed to generate documented results that can support scientific, quality and regulatory workflows.
Why contract research services matter
Contract research services enable organizations to access specialized laboratory capabilities without building every component internally. This can be particularly valuable when a project requires molecular identification of bacteria or fungi, authentication of species or strains, characterization of cell banks, contamination investigation, DNA sequencing, bioinformatics interpretation or a customized research workflow.
For pharma and biopharma companies, outsourced research support can help project teams manage timelines while maintaining access to specialist technical expertise. Research institutes and academic laboratories may benefit from an external partner that can support sample processing, sequencing, data analysis and reporting within a defined project scope.
geneOmbio’s contract research division is intended for business-to-business projects and supports pharmaceutical companies, biotechnology companies, academic institutes and research organizations. Its broader portfolio includes microbial identification, GMO testing, cell bank characterization, gene expression, sequencing, bioinformatics and customized research projects.
Microbial identification using DNA sequencing
Microbial identification is an essential component of pharmaceutical manufacturing, bioprocessing, microbiology research and contamination control. Correctly identifying an isolate can help organizations investigate an unexpected microbial signal, assess the identity of a production or probiotic strain, support environmental monitoring investigations and generate evidence for quality or regulatory reporting.
Traditional identification methods based only on morphology or biochemical characteristics may not always provide sufficient resolution. Closely related organisms can show similar phenotypic features, while environmental conditions may affect growth and biochemical reactions. DNA sequencing provides an additional molecular level of evidence that can improve identification, particularly when conventional methods produce an inconclusive or conflicting result.
16S, 18S and ITS sequencing
geneOmbio provides microbial identification using commonly applied taxonomic marker regions, including 16S rRNA sequencing for bacterial identification, 18S sequencing for selected eukaryotic microorganisms and ITS sequencing for fungal identification.
The 16S rRNA gene is widely used for bacterial taxonomic analysis, but accurate assignment depends on reference-database quality and interpretation. For fungal identification, the internal transcribed spacer region is an important molecular marker. Depending on the sample and project objective, a microbial identification workflow may involve DNA extraction, PCR amplification, sequencing, sequence-quality assessment, database comparison and scientific review.
geneOmbio’s microbial services also include PCR-based gene detection, virulence and antimicrobial-resistance gene sequencing, and identification of probiotic strains using 16S and gyrB gene sequencing.
Applications of microbial identification
Microbial identification services can support contamination investigations in pharmaceutical and biopharmaceutical facilities, identification of bacterial or fungal isolates, probiotic strain characterization, comparative analysis against reference strains, screening of antimicrobial-resistance or virulence-associated genes, microbial diversity studies and product verification.
A sequence result should not be treated as a database percentage alone. The report should consider sequence quality, marker choice, reference-strain coverage, taxonomic resolution and biological context. For quality assurance teams, this distinction is important: a useful report should provide traceable evidence and scientific interpretation rather than an unexplained automated output.
Cell bank characterization services
Cell banks are fundamental to the manufacture and development of many biological products, including vaccines, recombinant proteins, viral vectors and other biopharmaceutical products. Characterization of cell substrates and cell banks helps establish identity, purity and suitability for their intended use.
geneOmbio offers cell bank characterization services covering master cell banks, working cell banks and end-of-production cell banks. The appropriate testing panel depends on the cell substrate, product modality, manufacturing process and regulatory pathway. A single generic checklist is not suitable for every development program; testing should be scoped to the specific project.
What cell bank characterization may address
A cell bank characterization program may include testing related to cell identity, species confirmation, genetic or molecular identity, purity, microbial contamination, mycoplasma where applicable, adventitious agents, viral safety considerations, stability and comparability requirements.
The exact panel must be defined according to the study design and applicable guidance. A well-designed program can help confirm that the intended cell substrate has been used, detect potential contamination or cross-contamination, establish documented evidence for quality review, support comparability when a cell bank or manufacturing process changes, and organize information for technical or regulatory documentation.
DNA barcoding for authentication
DNA barcoding uses a standardized genetic region, or barcode, to support the identification and authentication of biological material. It is useful when morphology is unavailable, the sample is processed, different life stages are difficult to distinguish or molecular confirmation is required.
DNA barcoding can support species authentication, strain verification, raw-material verification, adulteration investigations, mislabeling assessments, research collections, biodiversity studies and microbial or biological-source confirmation. The choice of barcode depends on the organism and purpose of the study. For bacteria, 16S rRNA-based analysis may be appropriate in many cases, while fungal identification frequently uses ITS-based analysis.
DNA barcoding should be designed around the biological question rather than applied as a fixed universal assay. Important considerations include sample quality, DNA integrity, marker selection, PCR performance, sequencing quality, reference coverage and the required level of taxonomic resolution.
Integrated support from one genomics partner
Microbial identification, cell bank characterization and DNA barcoding are often connected within a broader product-development or quality program. A biopharmaceutical organization may need to characterize a cell substrate, investigate microbial contamination and authenticate a biological material during the same development cycle.
Working with one contract research partner can simplify sample coordination, method selection, data integration, report review and technical follow-up. geneOmbio positions its services as an integrated option for identity work across cell banks, species authentication and microbial contamination investigations.
Quality systems and technical infrastructure
Quality and traceability are central considerations when selecting contract research services. A laboratory should be able to demonstrate defined procedures, appropriate equipment, trained personnel, sample tracking and a reporting process suited to the intended use of the data.
geneOmbio’s stated capabilities include NABL accreditation for biological testing according to ISO/IEC 17025:2017, medical-testing accreditation according to ISO 15189:2012, recognition of its in-house R&D unit by the Department of Scientific and Industrial Research, and participation in external quality-assessment or proficiency-testing programs.
The laboratory infrastructure includes biosafety facilities, automated nucleic-acid extraction, segregated molecular laboratory areas, real-time PCR, conventional PCR, Sanger sequencing, flow cytometry, gel documentation, bioinformatics workstations, statistical-analysis expertise, LIMS-based reporting and sample tracking, and microbiology and clean-room facilities.
Custom project design and reporting
Not every genomics project fits a standard service package. Research institutes and biopharma companies may require a customized workflow involving multiple methods, comparative analysis or additional bioinformatics.
A customized project may include consultation, workflow design, sample review, laboratory testing, bioinformatics analysis, scientific review, documented reporting and a technical discussion. geneOmbio describes support for custom research projects and in-house-developed assays and analysis protocols. Its project experience includes recombinant protein work, gene-expression analysis, plant ploidy assessment, metagenomics, assay development, pathogen detection, genotyping and probiotic-strain analysis.
Who can benefit from geneOmbio’s services?
geneOmbio’s contract research services may be relevant to pharmaceutical companies developing or manufacturing biological products, biopharmaceutical companies working with cell substrates or microbial processes, QA and QC teams investigating contamination or identity concerns, microbiology laboratories requiring sequencing-based isolate identification, research institutes, academic laboratories, food and agriculture organizations, animal-health organizations and CROs seeking a technical partner for specialized genomics workflows.
The appropriate service depends on the project objective. Microbial identification may be suitable for an unknown isolate or contamination investigation. DNA barcoding may be more appropriate for species or strain authentication. Cell bank characterization is relevant when a cell substrate must be evaluated as part of a biological-product workflow.
Start a contract research project
Selecting the correct method is the first step toward obtaining useful molecular data. Before submitting samples, clients should share information about the organism or cell substrate, sample history, expected result, regulatory or publication requirements and any previous testing.
geneOmbio Technologies provides contract research support across microbial identification, cell bank characterization, DNA barcoding and related molecular research services. Its combination of sequencing, microbiology, bioinformatics, quality systems and custom project capability can help pharma, biopharma, research and QA teams address specialized testing requirements through a structured external partnership.
To discuss sample-specific requirements, project design, turnaround time or reporting expectations, contact geneOmbio Technologies at
+91 9960000984 or visit the contract research services page
Frequently asked questions
What contract research services does geneOmbio provide?
geneOmbio provides B2B contract research services including microbial identification, DNA barcoding, cell bank characterization, GMO testing, gene-expression studies, sequencing, bioinformatics and customized research projects.
Which sequencing methods are used for microbial identification?
The service portfolio includes 16S, 18S and ITS sequencing, with additional options such as gyrB analysis, whole-genome sequencing and comparative analysis depending on the project.
Can cell bank characterization panels be customized?
Yes. Panels can be designed around the cell substrate, product modality, target regulatory geography and the requirements for master, working or end-of-production cell banks.
Is the testing suitable for regulatory or publication-related work?
geneOmbio’s documented methods, quality systems and reports are intended to support research, quality and regulatory workflows. Sequence data and reports may also be formatted for GenBank submission and journal reporting where relevant.
How can a client submit a sample?
Clients should contact geneOmbio for sample-specific guidance before shipment.
